Long-term outcomes in patients with stage IV neuroblastoma

Mora, 2002, Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma, Cancer, 94, 2756, 10.1002/cncr.10548 Grosfeld, 2000, Risk-based management of solid tumors in children, Am J Surg, 180, 322, 10.1016/S0002-9610(00)00489-X Kaneko, 2002, Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification, J Pediatr Hematol Oncol, 24, 613, 10.1097/00043426-200211000-00004 Kawa, 1999, Long-term survivors of advanced neuroblastoma with MYCN amplification: a report of 19 patients surviving disease-free for more than 66 months, J Clin Oncol, 17, 3216, 10.1200/JCO.1999.17.10.3216 Tweddle, 2001, OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age, Med Pediatr Oncol, 36, 239, 10.1002/1096-911X(20010101)36:1<239::AID-MPO1058>3.0.CO;2-G Kaneko, 1998, Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status, Med Pediatr Oncol, 31, 1, 10.1002/(SICI)1096-911X(199807)31:1<1::AID-MPO1>3.0.CO;2-H Trebo, 1999, Long-term survival of a stage 4 neuroblastoma patient despite persistent bone marrow disease following autologous bone marrow transplantation, Med Pediatr Oncol, 33, 585, 10.1002/(SICI)1096-911X(199912)33:6<585::AID-MPO13>3.0.CO;2-Y Berthold, 2003, Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age, Cancer Lett, 197, 11, 10.1016/S0304-3835(03)00076-4 Klaassen, 2003, High-risk neuroblastoma in Ontario: a report of experience from 1989 to 1995, J Pediatr Hematol Oncol, 25, 8, 10.1097/00043426-200301000-00004 De Bernardi, 2003, Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma, J Clin Oncol, 21, 1592, 10.1200/JCO.2003.05.191 Shimada, 1984, Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas, J Natl Cancer Inst, 73, 405, 10.1093/jnci/73.2.405 Selig, 1993, Ferritin production and desferrioxamine cytotoxicity in human neuroblastoma cell lines, Anticancer Res, 13, 721 Quinn, 1980, Serum lactic dehydrogenase, an indicator of tumor activity in neuroblastoma, J Pediatr, 97, 89, 10.1016/S0022-3476(80)80139-9 Nakagawara, 2001, Trk receptor tyrosine kinases: a bridge between cancer and neural development, Cancer Lett, 169, 107, 10.1016/S0304-3835(01)00530-4 Combaret, 1997, Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma, Eur J Cancer, 33, 2101, 10.1016/S0959-8049(97)00236-0 Berthold, 1991, Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma, In Vivo, 5, 245 Look, 1991, Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study, J Clin Oncol, 9, 581, 10.1200/JCO.1991.9.4.581 Brodeur, 1977, Chromosomal aberrations in human neuroblastomas, Cancer, 40, 2256, 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1 Schwab, 1983, Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor, Nature, 305, 245, 10.1038/305245a0 Savelyeva, 1994, Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells, Am J Hum Genet, 55, 334 Seeger, 1985, Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N Engl J Med, 313, 1111, 10.1056/NEJM198510313131802 Riley, 2004, A systematic review of molecular and biological tumor markers in neuroblastoma, Clin Cancer Res, 10, 4, 10.1158/1078-0432.CCR-1051-2 Simon, 2003, Tumour markers are poor predictors for relapse or progression in neuroblastoma, Eur J Cancer, 39, 1899, 10.1016/S0959-8049(03)00376-9 Lahdenne, 2002, Clinical use of tumor markers in childhood malignancies, Ann Med, 34, 316, 10.1080/078538902320772070 Escobar, 2005, Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints, J Pediatr Surg, 40, 349, 10.1016/j.jpedsurg.2004.10.032 Grosfeld, 1986, Neuroblastoma in infants and childhood, 63 Grosfeld, 1993, Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome, Semin Pediatr Surg, 2, 37 Shimada, 1999, The International Neuroblastoma Pathology Classification (the Shimada system), Cancer, 86, 364, 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7 Shimada, 1999, Terminology and morphologic criteria of neuroblastic tumors. Recommendations by the International Neuroblastoma Pathology Committee, Cancer, 86, 349, 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y Shimada, 2001, International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group, Cancer, 92, 2451, 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S Shimada, 2003, The International Neuroblastoma Pathology Classification, Pathologica, 95, 240 La Quaglia, 2004, The impact of gross total resection on local control and survival in high-risk neuroblastoma, J Pediatr Surg, 39, 412, 10.1016/j.jpedsurg.2003.11.028 Kiely, 1993, Radical surgery for abdominal neuroblastoma, Semin Surg Oncol, 9, 489, 10.1002/ssu.2980090606 Kaneko, 1997, Is extensive surgery required for treatment of advanced neuroblastoma?, J Pediatr Surg, 32, 1616, 10.1016/S0022-3468(97)90466-8 Von Schweinitz, 2002, The impact of surgical radicality on outcome in childhood neuroblastoma, Eur J Pediatr Surg, 12, 402, 10.1055/s-2002-36952